M2 PRESSWIRE-February 15, 2011-ShamrockStocks.com: Lucky Picks of The Day: (OTCBB:SRCO) - (OTCBB:RGRX)- (OTCBB:GLMB)(C)1994-2011 M2 COMMUNICATIONS
RDATE:14022011
Rochester NY -- www.shamrockstocks.com names (OTCBB:SRCO) Sparta Commercial Services, Inc, (OTCBB:RGRX) RegeneRx Biopharmaceuticals, Inc., and (OTCBB:GLMB) Global MobileTech, Inc. it's "Lucky Picks of the Day!
To feature your publicly traded company in our alers email us at info@shamrockstocks.com.
Also, you can receive up to the minute stock alerts via our Twitter page www.twitter.com/shamrockstocks
Visit http://www.shamrockstocks.com/disclaimer.html for current profiles
Visit: www.shamrockstocks.com
About Sparta Commercial Services, Inc.
Sparta Commercial Services, Inc., www.spartacommercial.com, is a New York-based, nationwide financial services company offering financing and leasing products to consumers and retail powersports and automobile dealers. Sparta also serves municipal and governmental agencies nationwide with its Municipal Lease Program, which offers financing for essential equipment for the law enforcement and emergency response communities.
Our subsidiary, Specialty Reports, Inc. d/b/a Cyclechex, is in the business of offering online access to title histories and salvage information for various classes of previously owned assets. Cyclechex's initial product release is the Cyclechex Motorcycle History Report.
About NADAguides
NADAguides (http://www.nadaguides.com) is the largest publisher of vehicle pricing and information for new and used cars, classic cars, motorcycles, boats, RVs, and manufactured homes. NADAguides offers in-depth shopping and research tools in addition to the most market-reflective pricing available. The company also produces software, raw data, web services, web-syndicated products and print guidebooks.
News Today:
NEW YORK, NY, Feb 14, 2011) -- Sparta Commercial Services, Inc. (OTCBB: SRCO)
News Highlights
-- Sparta Commercial Services, Inc. today announced that via a new
relationship with NADAguides, the most comprehensive vehicle
information provider on the Internet today, in-market buyers can now
obtain motorcycle history reports on NADAguides.com from Cyclechex --
the leading provider of motorcycle history reports.
-- With Cyclechex as another available resource, NADAguides is able to
provide in-market buyers with yet another valuable piece of
information to help consumers make a confident and comfortable vehicle
purchase.
-- Cyclechex provides consumers with comprehensive motorcycle history
reports for previously registered street bikes, dirt bikes and
scooters dating back to 1981. The data provided by Cyclechex is pulled
from governmental agencies across multiple states. Data includes
information such historical title records with number of previous
owners, last recorded odometer reading, and any disclosed damage to
the vehicle, salvaged, rebuilt or stolen titles, VIN decoding, crushed
vehicle notification, vehicle specifications, and manufacturers'
recall history.
-- NADAguides.com provides pricing and data for street bikes, dirt bikes
and vintage motorcycles as well as side cars and trailers dating back
to 1905. With so much data available to consumers, NADAguides finds it
essential to also provide helpful resources such as insurance and
dealer quotes, credit reports and now motorcycle history reports with
Cyclechex. These are the resources consumers can rely upon to help
make a well-informed decision with the utmost ease and confidence.
-- Cyclechex history reports can be purchased through NADAguides.com for
$24.95 each or three for $49.95.
Key Quotes
-- Lenny Sims, vice president of operations NADAguides: "NADAguides is
always aiming to provide consumers with a website that is rich with
data and resources that can be trusted and relied upon for research
and purchasing decisions. In-market buyers come to our site to have
their questions answered so that they can walk into a dealership with
assurance that they are making a smart purchase. Adding motorcycle
history reports by Cyclechex is just one more step we have taken to
assist consumers with making a purchase they can be sure of."
-- Anthony L. Havens, CEO of Cyclechex: "Given NADAguides' dominance and
widespread use in the powersports marketplace, we are extremely
enthusiastic about this new relationship. Our alliance with NADAguides
strengthens the consumer's ability to make a well-informed used
motorcycle purchase."
Visit: www.shamrockstocks.com
About RegeneRx Biopharmaceuticals, Inc. (www.regenerx.com)
RegeneRx is focused on the development of a novel therapeutic peptide, Thymosin beta 4, or TB4, for tissue and organ protection, repair and regeneration. RegeneRx currently has three drug candidates in clinical development and has an extensive worldwide patent portfolio covering its products.
RGN-352 is an injectable formulation to treat cardiovascular and central nervous system diseases, as well as other medical indications. RegeneRx is initially targeting RGN-352 for the treatment of patients who have suffered an acute myocardial infarction, or heart attack. Recent pre-clinical efficacy data suggests that RGN-352 may also benefit patients with multiple sclerosis, stroke and traumatic brain injury. RegeneRx has successfully completed a Phase 1 clinical trial with RGN-352 in which the drug candidate was found to be safe and well-tolerated. The company has initiated a Phase 2 clinical trial and expects to enroll the first patient by early 2011 at approximately 25 clinical sites in the U.S., Israel, and Russia. RegeneRx recently received a $3 million, three-year development grant from the NIH to support the company's acute myocardial infarction program.
RGN-259 is a sterile, preservative-free topical eye drop for ophthalmic indications. Based on recent human clinical data, RegeneRx is currently supporting a physician-sponsored Phase 2 dry eye study with RGN-259. Previously, seven patients with non-healing corneal ulcers were treated with RGN-259 under compassionate use INDs. Five had complete healing and two had substantial healing of their wounds. Three additional patients with corneal defects, called punctate keratitis, had no evidence of healing although they did report reduction in eye inflammation and increased comfort.
RGN-137, a topical gel formulation, is currently being evaluated by RegeneRx in a Phase 2 clinical trial for the treatment of the orphan skin disease epidermolysis bullosa. Other potential uses for RGN-137 include the treatment of chronic dermal wounds and reduction of scar tissue. RegeneRx previously received $675,000 in grants from the U.S. FDA to support this clinical trial.
In addition to the pharmaceutical product candidates described above, RegeneRx is pursuing the commercial development of peptide fragments of TB4 for potential cosmeceutical use. RegeneRx holds numerous patents and patent applications worldwide related to its products and holds an exclusive worldwide license from the National Institutes of Health, as well as other licenses related to TB4. The Company recently received $733,438 in funding under the Patient Protection and Affordable Care Act to support each of its product candidates.
News Today:
ROCKVILLE, Md., Feb 14, 2011-- RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) ("the Company" or "RegeneRx") announced today that the Company's President and Chief Executive Officer, J.J. Finkelstein, will present at the 13th Annual BIO CEO & Investor Conference being held at the Waldorf Astoria Hotel in New York City on February 15th, at 10:30 a.m. Eastern time.
To access the live audio webcast and slide presentation investors may click on the following link: http://www.veracast.com/webcasts/bio/ceoinvestor2011/58206315.cfm or visit RegeneRx's homepage at www.regenerx.com. An archived copy of the presentation will also be available on RegeneRx's website.
Visit: www.shamrockstocks.com
About Global MobileTech, Inc.
Global MobileTech, Inc. ("GLMB") based in Spokane, WA with Asian operations located in Malaysia, is engaged in the provision of renewable energy, mobile VoIP communications and mobile advertising applications and services. The Company's operations are organized under two business segments. The first segment handles the development and sale of mobile Voice over Internet Protocol or VoIP communications and mobile advertising applications. The second segment is involved in the design, integration, marketing and sale of solar photovoltaic or PV-wind and solar PV-biomass hybrid power generation applications. The biomass used in the power generation system includes oil palm bio-wastes and forest residues. The target market for GLMB's products and services include customers from Asia, Europe and the United States. For more information, please visit www.globalmobiletech.com. Information on our website does not comprise a part of this press release.
News Today
SPOKANE, WA, Feb 14, 2011 -- Global MobileTech, Inc. (OTCBB: GLMB) today announced its second quarter fiscal 2011 financial results. For the second quarter of fiscal 2011, the Company reported revenues of $8.18 million and income before tax of $708,906, compared to revenues of $8.05 million and income before tax of $890,858 in the first quarter of fiscal 2011.
KEY HIGHLIGHTS
Three Months Six Months
Ended Ended
December 31, December 31,
2010 2010
Revenues $8,183,586 $16,237,712
Gross Profit $1,267,192 $2,513,600
Income Before Tax $708,906 $1,599,760
Net Income $460,792 $1,195,423
Basic earnings per share $0.15 $0.49
Diluted earnings per share $0.14 $0.47
Weighted average number of shares ('000')
Basic 3,144 2,448
Diluted 3,235 2,527
Aik Fun Chong, President & CEO, stated, "We continue to meet critical milestones in our renewable energy business and expect to keep improving revenues for this segment for the remaining quarters of 2011."
Revenues in the second quarter of fiscal 2011 were generated by our Malaysian subsidiary, Info-Accent Sdn Bhd. Our mobile VoIP communications and mobile advertising business segment accounted for 72% of our total revenues. Revenues from our renewable energy segment accounted for 28% of our total revenues.
For the second quarter of fiscal 2011, gross profit was $1.27 million compared to $1.25 million in the first quarter of fiscal 2011. Gross profit in the second quarter derived from our mobile VoIP communications and mobile advertising segment was $803,262 or 63% of our total gross profit while gross profit from our renewable energy segment was $463,930 or 37%. Gross profit margin in the second quarter from our renewable energy segment was 20% compared with 14% from our mobile VoIP communications and mobile advertising segment.
Income before tax for the three months ended December 31, 2010 totaled $708,906 compared to $890,858 for the three months ended September 30, 2010. Operating profit margin in the second quarter of fiscal 2011 from our renewable energy segment was 7.9% compared with 8.9% from our mobile VoIP communications and mobile advertising segment. For the second fiscal quarter, net income was $460,792 and for the six months ended December 31, 2010, net income was $1,195,423 or earnings per share of $0.47.
Visit: www.shamrockstocks.com
About Shamrockstocks.com
Shamrockstocks.com is a website that profiles stocks of interest. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by Shamrockstocks. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed.
For additional information, please contact info@shamrockstocks.com, www.shamrockstocks.com or www.twitter.com/shamrockstocks.
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com)).
Комментариев нет:
Отправить комментарий